<DOC>
	<DOC>NCT00985010</DOC>
	<brief_summary>Objective: Report manganese serum levels and mortality in encephalopathic patients. Patients and participants: Consecutive patients aged &gt; 18 years, with hepatic encephalopathy and informed consent signed by their families. Interventions: Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer. Hypothesis: There is a difference in the manganese levels between male and female patients.</brief_summary>
	<brief_title>Manganese in Women With Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Manganese</mesh_term>
	<criteria>Consecutive patients aged &gt; 18 years With hepatic encephalopathy Informed consent signed by their families Portal bypass surgery Cancer of any localization Known malignancy and other severe diseases which shorten life expectancy &lt; 6 months Psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>hepatic encephalopathy</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>manganese</keyword>
	<keyword>mortality</keyword>
	<keyword>prognosis.</keyword>
</DOC>